🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,871.50
+1.50 (0.08%)
Nov 18, 2026, 3:28 PM IST

NSE:SUNPHARMA Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
203,68497,705102,68892,85746,23745,083
Short-Term Investments
132,01844,33050,96653,71260,04144,695
Trading Asset Securities
-193,131107,57344,33245,02236,771
Cash & Short-Term Investments
335,701335,166261,227190,901151,300126,548
Cash Growth
20.41%28.30%36.84%26.17%19.56%32.33%
Accounts Receivable
178,048155,097130,610112,602114,568105,035
Other Receivables
-3,6644,9136,1884,1363,509
Receivables
178,583159,288136,007119,440119,117110,243
Inventory
125,924120,585107,593102,949109,68392,392
Prepaid Expenses
-4,5893,7504,1353,7182,862
Other Current Assets
52,45919,28417,66717,32515,01516,601
Total Current Assets
692,666638,912526,245434,750398,833348,646
Property, Plant & Equipment
130,049124,948112,703113,001113,537111,689
Long-Term Investments
32,47437,89146,97764,41254,51749,592
Goodwill
100,49498,33189,39485,69083,58065,913
Other Intangible Assets
139,198135,46290,20587,33093,26861,918
Long-Term Accounts Receivable
----108.3193.7
Long-Term Deferred Tax Assets
39,11040,46544,07641,03735,18928,496
Other Long-Term Assets
14,36411,82711,37828,76928,39631,623
Total Assets
1,148,3841,087,852921,006854,997807,436698,078

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
74,19073,33861,84356,53356,81544,898
Accrued Expenses
-25,24218,85616,88915,12714,833
Short-Term Debt
26,26840,50418,67128,44459,5834,685
Current Portion of Long-Term Debt
----2,3962,323
Current Portion of Leases
1,9781,8411,3681,2571,2811,078
Current Income Taxes Payable
26,02313,5007,3324,1173,0871,756
Current Unearned Revenue
-2,9571,3441,2651,5671,930
Other Current Liabilities
107,45768,83972,52861,33959,214100,582
Total Current Liabilities
235,916226,220181,942169,844199,070172,085
Long-Term Debt
666.9312.625.213.3-2,299
Long-Term Leases
3,5003,6163,5573,0235,5992,518
Long-Term Unearned Revenue
-3,4803,7674,8875,6996,188
Pension & Post-Retirement Benefits
-5,0274,5353,9973,2623,434
Long-Term Deferred Tax Liabilities
3,1003,7801,9241,719316.9318.6
Other Long-Term Liabilities
9,5646,618395.2253.7334.6575.4
Total Liabilities
252,747249,055196,146183,737214,281187,417

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
2,3992,3992,3992,3992,3992,399
Additional Paid-In Capital
-11,87411,87411,87411,87411,874
Retained Earnings
-694,677614,525537,452472,009412,363
Comprehensive Income & Other
890,400126,75193,38284,94273,67153,476
Total Common Equity
892,799835,701722,180636,668559,954480,112
Minority Interest
2,8393,0972,67934,59233,20130,549
Shareholders' Equity
895,637838,797724,860671,259593,155510,661
Total Liabilities & Equity
1,148,3841,087,852921,006854,997807,436698,078

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
32,41346,27323,62232,73768,85912,903
Net Cash (Debt)
303,288288,893237,605158,16482,441113,645
Net Cash Growth
33.81%21.58%50.23%91.85%-27.46%99.57%
Net Cash Per Share
126.53120.4199.0365.9234.3647.37
Filing Date Shares Outstanding
2,3962,3992,3992,3992,3992,399
Total Common Shares Outstanding
2,3962,3992,3992,3992,3992,399
Working Capital
456,750412,692344,303264,906199,763176,562
Book Value Per Share
372.65348.31300.99265.35233.38200.10
Tangible Book Value
653,106601,909542,581463,648383,105352,282
Tangible Book Value Per Share
272.60250.86226.14193.24159.67146.82
Land
-8,2667,8568,1736,6766,448
Buildings
-74,41565,32563,61061,39557,836
Machinery
-169,555152,025146,265139,645132,031
Construction In Progress
-13,80712,34311,0779,6347,975